-
公开(公告)号:JPH0322398B2
公开(公告)日:1991-03-26
申请号:JP5290178
申请日:1978-05-02
发明人: FUJINO MASAHIKO , SHINAGAWA SUSUMU , KAWAI KYOHISA
IPC分类号: C07K5/10 , A61K38/00 , A61K38/22 , A61P25/04 , C07K1/06 , C07K1/113 , C07K14/575 , C07K14/655 , C07K14/70
-
公开(公告)号:JPH036160B2
公开(公告)日:1991-01-29
申请号:JP32074287
申请日:1987-12-17
发明人: FUJINO MASAHIKO , NISHIMURA TADASHI
-
公开(公告)号:JPH0272877A
公开(公告)日:1990-03-13
申请号:JP27445488
申请日:1988-11-01
发明人: ONDA HARUO , ITO YASUAKI , FUJINO MASAHIKO , MAZAKI TOMOO , YANAGISAWA MASASHI , KURIHARA HIRONORI
IPC分类号: C12N15/09 , A61K38/00 , A61P7/04 , A61P9/00 , C07K14/47 , C07K14/52 , C07K14/575 , C12N1/16 , C12N1/19 , C12N1/20 , C12N1/21 , C12N5/10 , C12P21/02 , C12R1/19 , C12R1/865 , C12R1/91
摘要: NEW MATERIAL:A DNA containing a DNA coding endoserine. USE:Production of a peptide (endoserine) having angiotonic action by gene recombination technique. PREPARATION:A DNA coding a part of the peptide of swine endoserine is chemically synthesized. A cDNA coding human endoserine is cloned from a cDNA library originated from human placenta by using the above synthesized DNA as a probe. The whole base sequence of the cDNA has been determined and the amino acid sequences of human endoserine and its precursor protein have been cleared as shown in the figure.
-
公开(公告)号:JPH0210146B2
公开(公告)日:1990-03-06
申请号:JP28556288
申请日:1988-11-10
发明人: FUJINO MASAHIKO , NISHIMURA TADASHI
IPC分类号: C07C311/64 , C07K1/06 , C07K1/113
-
公开(公告)号:JPH0249799A
公开(公告)日:1990-02-20
申请号:JP8653889
申请日:1989-04-05
IPC分类号: C07D233/64 , C07K1/06 , C07K14/00
摘要: PURPOSE:To obtain peptides using a protecting group capable of removal under so mild conditions as to be stable against acids, bases and reduction by protecting a imidazole group of histidine with 4-methoxy-2,3,6-trimethylbenzenesulfonyl group and synthesizing a peptide. CONSTITUTION:In production of a peptide containing histidines, imidazole groups of the histidines are reacted with 4-methoxy-2,3,6-trimethylbenzenesulfonyl chloride to form histidine derivatives represented by the formula (R is H or protective group of-amino group; 4-Methoxy-2,3,6-trimethylbenzenesulfonyl group is bonded to N at 1 or 3 position of A ring.) where each imidazole group is protected with a 4-methoxy-2,3,6-trimethylbenzenesulfonyl group and then peptide condensation is carried out. The protecting groups are subsequently removed using an acid or 1-hydroxybenzotriazole to produce the objective peptide.
-
公开(公告)号:JPH0157109B2
公开(公告)日:1989-12-04
申请号:JP450681
申请日:1981-01-14
IPC分类号: C07C67/00 , C07C231/00 , C07D209/20 , C07K1/06 , C07K5/06 , C07K5/08 , C07K5/10 , C07K7/06 , C07K7/08 , C07K7/23
-
公开(公告)号:JPS63211262A
公开(公告)日:1988-09-02
申请号:JP2824488
申请日:1988-02-09
发明人: FUJINO MASAHIKO , NISHIMURA TADASHI
IPC分类号: C07K1/06 , C07C67/00 , C07C301/00 , C07C311/64 , C07K1/113
摘要: NEW MATERIAL:A compound shown by formula I (R1 and R5 are CH3 or OCH3; R2 and R4 are CH3 or H; R3 is CH3 or OCH3; R6 is H or alpha-amino protecting group) and a salt thereof. USE:An intermediate for producing peptide. PREPARATION:alpha-Amino group of arginine is protected with carbobenzoxy group, etc., and the resultant substance is reacted with a halogenide containing a substituted benzenesulfonyl group shown by formula II at -5-10 deg.C to give a compound shown by formula I. The reaction is preferably carried out in the presence of a base such as NaOH, etc., in a solvent such as water, acetone, DMF or THF.
-
公开(公告)号:JPS6319519B2
公开(公告)日:1988-04-22
申请号:JP14463486
申请日:1986-06-19
发明人: FUJINO MASAHIKO , KITADA CHEKO
IPC分类号: C12N1/16 , C07K7/08 , C07K14/37 , C07K14/41 , C07K14/575
-
公开(公告)号:JPS625995A
公开(公告)日:1987-01-12
申请号:JP14463386
申请日:1986-06-19
发明人: FUJINO MASAHIKO , KITADA CHIEKO
IPC分类号: C12N1/16 , C07K7/06 , C07K14/37 , C07K14/41 , C07K14/575
摘要: NEW MATERIAL:The compound of formula H-Tyr-Pro-Glu-Ile-Ser-Trp-Thr-Arg- Asn-Gly-Cys(S-farnesyl)-N-H2 wherein the C-terminal may be carboxylic acid. USE:It has the activity to promote the formation of conjugating tube and is useful for the breeding of yeast and improvement of species and as a biochemical reagent, etc. PREPARATION:For example 1, equivalent of the peptide of formula H-Tyr-Pro- Glu-Ile-Ser-Trp-Thr-Arg-Asn-Gly-Cys-OH (or -NH2) is made to react with prefer ably 2-4 equivalent of farnesyl bromide in a hydrous DMF solvent (preferably having a water-content of 30-60 vol%) in the presence of preferably 2-4 equiva lent of magnesium oxide at 0-30 deg.C for 3-12hr.
-
-
-
-
-
-
-
-
-